USPTO serial 79253893
AMOCELL
Reviewed by CopyMark Law Group
Reg. 5969770Status 709
- Filing date
- Status date
- Registration date
- Jan 28, 2020
- Examiner
- YAO, GRETTA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AMOCELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey D. Larson
Jeffrey D. Larson Holland & HartP.O. Box 8749, TM DocketingAttn: Trademark DocketingDenver, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the biochemical and chemical industry; solutions for cell preservation other than for medical, veterinary or medical research purposes; biochemical preparations for scientific purposes; biological preparation for use in cell cultures other than for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 005 | Solutions for cell preservation for medical and veterinary purposes; preparations for medical and veterinary purposes namely, solutions for cell preservation for research relating to medical and veterinary treatment; reagents for medical purposes; medical diagnostic reagents; veterinary diagnostic reagents; biochemical preparations for medical or veterinary purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Factory, Inc.
- Other trademarks owned by Otsuka Pharmaceutical Factory, Inc.
- Other trademarks owned by Otsuka Pharmaceutical Factory, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named AMOCELL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2026 | C71T | CANCELLED SECTION 71 | — |
| Mar 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 28, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 29, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 9, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 9, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 28, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 23, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 23, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 23, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 9, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2019 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 4, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 4, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 30, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 26, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 7, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |